This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Amruta Mhashilkar
Director, Formulation and Process Development at Catalent
Speaker

Profile

Amruta Mhashilkar is Director of Formulation and Process Development at Catalent, where she leads a team of 35+ scientists and technical professionals and oversees a portfolio of 80+ programs spanning preclinical through commercial stages. She specializes in lipid-based drug delivery systems, including softgels and complex oral formulations, with a focus on enabling bioavailability and scalable, phase-appropriate manufacturing solutions. Amruta has supported over 100 client programs across leading pharmaceutical and biotechnology companies and has contributed to multiple successful Rx product launches. Her expertise spans CMC strategy, formulation development, scale-up, and regulatory support across IND, NDA, ANDA, and ANADA pathways. She is known for combining deep technical expertise with strong execution and cross-functional leadership to accelerate development timelines and translate complex molecules into commercially viable therapies.

Agenda Sessions

  • Overcoming Barriers to Oral Delivery of Macromolecules Through Innovative Technologies

    1:00pm